A high-throughput assay for connexin 43 (Cx43, GJA1) gap junctions using codon-optimized aequorin

Nazia Haq1, David Grose, Emma Ward

  • 1Biological Reagents and Assay Development, GlaxoSmithKline R&D, Stevenage, United Kingdom.

Summary

This study presents a new high-throughput assay to screen for drugs targeting gap junctions (GJs) by measuring calcium transfer between cells. This method facilitates the discovery of novel therapeutic modulators for GJ-related conditions.